Prelude Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.56M Buy
39,423
+1,651
+4% +$65.2K 0.15% 168
2025
Q1
$1.14M Buy
37,772
+22,177
+142% +$669K 0.09% 226
2024
Q4
$545K Buy
+15,595
New +$545K 0.03% 482
2022
Q4
Sell
-5,341
Closed -$236K 1312
2022
Q3
$236K Sell
5,341
-2,087
-28% -$92.2K 0.01% 973
2022
Q2
$275K Buy
+7,428
New +$275K 0.01% 947
2020
Q4
Sell
-168
Closed -$8K 1146
2020
Q3
$8K Sell
168
-1,246
-88% -$59.3K ﹤0.01% 1118
2020
Q2
$83K Buy
+1,414
New +$83K ﹤0.01% 698
2019
Q4
Sell
-108
Closed -$6K 1579
2019
Q3
$6K Buy
+108
New +$6K ﹤0.01% 1055
2019
Q2
Sell
-1,087
Closed -$88K 1463
2019
Q1
$88K Buy
1,087
+692
+175% +$56K 0.01% 656
2018
Q4
$21K Sell
395
-15,779
-98% -$839K ﹤0.01% 918
2018
Q3
$834K Buy
+16,174
New +$834K 0.05% 261
2018
Q1
Sell
-350
Closed -$18K 1441
2017
Q4
$18K Sell
350
-31,979
-99% -$1.64M ﹤0.01% 1022
2017
Q3
$1.64M Buy
32,329
+27,759
+607% +$1.41M 0.15% 127
2017
Q2
$232K Sell
4,570
-434
-9% -$22K 0.02% 471
2017
Q1
$201K Buy
5,004
+2,590
+107% +$104K 0.02% 518
2016
Q4
$115K Buy
2,414
+2,035
+537% +$96.9K 0.01% 744
2016
Q3
$14K Sell
379
-1,776
-82% -$65.6K ﹤0.01% 1314
2016
Q2
$50K Sell
2,155
-963
-31% -$22.3K 0.01% 957
2016
Q1
$126K Sell
3,118
-6,950
-69% -$281K 0.02% 617
2015
Q4
$624K Buy
10,068
+2,837
+39% +$176K 0.1% 201
2015
Q3
$292K Buy
7,231
+121
+2% +$4.89K 0.04% 393
2015
Q2
$409K Sell
7,110
-500
-7% -$28.8K 0.06% 327
2015
Q1
$485K Buy
7,610
+26
+0.3% +$1.66K 0.07% 339
2014
Q4
$468K Buy
+7,584
New +$468K 0.07% 302
2014
Q2
Sell
-2,020
Closed -$87K 1840
2014
Q1
$87K Sell
2,020
-6,182
-75% -$266K 0.01% 935
2013
Q4
$327K Buy
8,202
+1,076
+15% +$42.9K 0.05% 429
2013
Q3
$268K Sell
7,126
-7,874
-52% -$296K 0.04% 392
2013
Q2
$403K Buy
+15,000
New +$403K 0.09% 257